全文获取类型
收费全文 | 291669篇 |
免费 | 26364篇 |
国内免费 | 19382篇 |
专业分类
耳鼻咽喉 | 2777篇 |
儿科学 | 3075篇 |
妇产科学 | 3694篇 |
基础医学 | 35380篇 |
口腔科学 | 4933篇 |
临床医学 | 38552篇 |
内科学 | 43276篇 |
皮肤病学 | 3558篇 |
神经病学 | 15933篇 |
特种医学 | 11875篇 |
外国民族医学 | 153篇 |
外科学 | 28971篇 |
综合类 | 46351篇 |
现状与发展 | 76篇 |
一般理论 | 25篇 |
预防医学 | 18072篇 |
眼科学 | 8846篇 |
药学 | 30578篇 |
252篇 | |
中国医学 | 15941篇 |
肿瘤学 | 25097篇 |
出版年
2024年 | 859篇 |
2023年 | 4360篇 |
2022年 | 11281篇 |
2021年 | 14507篇 |
2020年 | 10664篇 |
2019年 | 9446篇 |
2018年 | 10160篇 |
2017年 | 9115篇 |
2016年 | 8818篇 |
2015年 | 13489篇 |
2014年 | 16601篇 |
2013年 | 14820篇 |
2012年 | 22051篇 |
2011年 | 24334篇 |
2010年 | 14810篇 |
2009年 | 11921篇 |
2008年 | 15711篇 |
2007年 | 15427篇 |
2006年 | 15337篇 |
2005年 | 14916篇 |
2004年 | 9766篇 |
2003年 | 9375篇 |
2002年 | 7846篇 |
2001年 | 6534篇 |
2000年 | 6643篇 |
1999年 | 6819篇 |
1998年 | 4253篇 |
1997年 | 4133篇 |
1996年 | 3349篇 |
1995年 | 3084篇 |
1994年 | 2616篇 |
1993年 | 1685篇 |
1992年 | 2226篇 |
1991年 | 1914篇 |
1990年 | 1550篇 |
1989年 | 1323篇 |
1988年 | 1175篇 |
1987年 | 1055篇 |
1986年 | 856篇 |
1985年 | 615篇 |
1984年 | 383篇 |
1983年 | 279篇 |
1982年 | 184篇 |
1981年 | 170篇 |
1980年 | 134篇 |
1979年 | 156篇 |
1977年 | 55篇 |
1975年 | 64篇 |
1974年 | 60篇 |
1973年 | 56篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Fengxiu Ouyang Binyan Wang Lester M. Arguelles Xiping Xu Jianhua Yang Zhiping Li Liuliu Wang Xue Liu Genfu Tang Houxun Xing Craig Langman Xiaobin Wang 《Archives of osteoporosis》2007,2(1-2):29-43
Summary We prospectively examined bone growth patterns in 894 children aged 6–17 years at the baseline visit, with a 6-year follow-up.
Results show bone “tracking” over a six-year interval and sexual dimorphism of bone attained levels and timing of peak bone
growth. Our findings underscore childhood and adolescence as critical periods for building bone and developing gender differences.
Introduction Bone growth patterns were prospectively examined in 894 Chinese children (496 males), aged 6–17 yrs, from a population-based
twin cohort. Whole-body bone area (BA), bone mineral content (BMC), and bone mineral density (BMD) were measured by DEXA at
baseline and a 6-yr follow-up.
Methods Graphic smoothing plots and generalized estimating equations were used to model bone attained levels, growth, and “tracking”.
Results Attained levels of BMC and BA increased curvilinearly with age. Male attained levels were higher than females after age ∼15 yr,
but BMD was lower between 13–17 yrs (Tanner stage I to IV). In both genders, peak BMC and BMD growth lagged ∼2 yrs behind
peak BA growth, which lagged 2 yrs behind peak height growth. Peak bone growth occurred 1–3 yrs later in males. Over the 6-yr
follow-up, all bone measurements “tracked”, but “shifting” across ranks also occurred, and baseline tertile ranking influenced
bone growth. Females with early menarche had higher attained levels than females with late menarche at age 12–13 yrs.
Conclusion Our findings confirm and expand previous studies on peak bone growth conducted in Caucasian cohorts, particularly sexually
dimorphic and maturational effects. The significant “tracking” of bone measurements in this 6-yr follow-up study underscores
the importance that osteoporosis prevention should begin in childhood and adolescence.
Fengxiu Ouyang and Binyan Wang contributed equally to this article.
Source(s) of support: This study is supported in part by grant R01 HD049059, R01 HL0864619 and R01 AR045651 from the National
Institute of Health and by the Food Allergy Project. 相似文献
83.
84.
85.
86.
Gelin Xu Xinfeng Liu Wusheng Zhu Qin Yin Renliang Zhang Xiaobing Fan 《Blood coagulation & fibrinolysis》2007,18(2):193-197
This study evaluated the safety and efficacy of batroxobin in treating hyperfibrinogenemia for secondary stroke prevention. Patients with ischemic stroke or transient ischemic attack (TIA) were measured for plasma fibrinogen levels. Selected participants had concomitant hyperfibrinogenemia (plasma fibrinogen > or = 3.0 g/l). Patients enrolled between 1 July 2003 and 31 December 2004 were treated with batroxobin; patients enrolled between 1 January 2002 and 30 June 2003 were treated without batroxobin. Batroxobin was administered intermittently via intravenous injection at 3-monthly intervals. Patients in both groups were followed for 1 year. Any cerebrovascular events and suspected adverse events were recorded. In total, 112 ischemic stroke/TIA patients with concomitant hyperfibrinogenemia were enrolled, 52 being treated with batroxobin and 60 without batroxobin. Six patients (11.5%) with batroxobin and 16 patients (26.7%) without batroxobin had recurrent cerebral ischemic events during follow-up. Stroke/TIA recurrence in patients without batroxobin was higher than that in patients with batroxobin (P < 0.05). Two patients with batroxobin and two patients without batroxobin developed hemorrhagic stroke during follow-up. There were five deaths (9.6%) in the batroxobin group, and seven deaths (11.7%) in the nonbatroxobin group during follow-up (P > 0.05). Intermittent intravenous injection of batroxobin can efficiently reduce the risk for stroke/TIA recurrence in patients with concomitant hyperfibrinogenemia. 相似文献
87.
一般护理记录单是住院病历的一部分,根据卫生部、中医药管理局公布的《病历书写基本规范》(试行)的规定,一般护理记录的定义是:护士根据医嘱和病情对一般病人住院期间护理过程的客观记录,内容包括病人姓名、记录日期和时间、病情观察、护理措施和效果、护士签名。现将护士在一般护理书写中存在认识上的理解偏差分析如下。 相似文献
88.
Efficient high-frequency body coil for high-field MRI. 总被引:1,自引:0,他引:1
J T Vaughan G Adriany C J Snyder J Tian T Thiel L Bolinger H Liu L DelaBarre K Ugurbil 《Magnetic resonance in medicine》2004,52(4):851-859
The use of body coils is favored for homogeneous excitation, and such coils are often paired with surface coils or arrays for sensitive reception in many MRI applications. While the body coil's physical size and resultant electrical length make this circuit difficult to design for any field strength, recent efforts to build efficient body coils for applications at 3T and above have been especially challenging. To meet this challenge, we developed an efficient new transverse electromagnetic (TEM) body coil and demonstrated its use in human studies at field strengths up to 4 T. Head, body, and breast images were acquired within peak power constraints of <8 kW. Bench studies indicate that these body coils are feasible to 8 T. RF shimming was used to remove a high-field-related cardiac imaging artifact in these preliminary studies. P41RR13230 相似文献
89.
90.
Su Jin Lee Young Keun On Eun Jeong Lee Joon Young Choi Byung-Tae Kim Kyung-Han Lee 《Journal of nuclear medicine》2008,49(8):1277-1282
Vascular 18F-FDG uptake marker represents inflammation in atherosclerotic lesions, but whether inflammation can be reversed by risk-modifying interventions has not, to our knowledge, been demonstrated. In this study, we evaluated the change of vascular 18F-FDG uptake in response to lifestyle intervention on serial PET/CT scans and further assessed how the findings relate to atherogenic risk reduction. METHODS: A total of 60 healthy adults underwent 18F-FDG PET/CT scans and atherogenic risk-factor assessment at baseline and again after 17.1 +/- 8.3 mo of practicing lifestyle modification. The PET/CT images were evaluated for the presence of vascular 18F-FDG lesions, and vessel-to-blood-pool 18F-FDG ratios were measured. Indices from summed ratios of positive lesions were compared and correlated to atherogenic risk factors. RESULTS: At follow-up, significant reductions in diastolic blood pressure (P < 0.05), total cholesterol (P < 0.05), and low-density lipoprotein level (P < 0.05) and an increase in high-density lipoprotein (HDL) level (P < 0.0001) were demonstrated. On the initial PET/CT scan, 50 of 60 subjects showed 1 or more 18F-FDG-positive lesions (5.9 +/- 5.0/subject), leading to a total of 352 vascular sites. On follow-up, 18F-FDG-positive lesions were significantly reduced to 2.1 +/- 2.2 sites per subject (P < 0.0001) and a total of 124 sites (64.8% reduction). Follow-up 18F-FDG-positive rates were significantly reduced for the aorta and iliac arteries. In addition, significant reductions in the whole-body 18F-FDG index from 1.39 +/- 1.23 to 0.53 +/- 0.59 (P < 0.0001) and carotid 18F-FDG index from 0.08 +/- 0.16 to 0.03 +/- 0.06 (P = 0.01) were shown. The whole-body 18F-FDG index correlated with total cholesterol (P < 0.05) and HDL level (P < 0.05), and the magnitude of reduction in the 18F-FDG index closely correlated to the amount of increase in plasma HDL level (P = 0.005). CONCLUSION: Our study demonstrated that vascular 18F-FDG uptake is reversed in response to atherogenic risk reduction by lifestyle intervention and that the magnitude of improvement correlates to increases in plasma HDL levels. Thus, serial 18F-FDG PET/CT may be useful for monitoring improvements in the inflammatory component of atherosclerotic lesions in response to risk modification. 相似文献